Cell-penetrating peptides (CPPs) are short peptide sequences that can ferry drug-loaded nanoparticles across cell membranes, with applications expanding from cancer therapy to cardiovascular and HIV treatment.
5+ therapeutic areasCPPs now have applications beyond cancer — including atherosclerosis, thrombin detection, tumor imaging, and HIV therapy
What the researchers found
CPPs can effectively assist nanotherapeutics in crossing cell membranes, with demonstrated applications in cancer therapy, tumor imaging, atherosclerosis evaluation, thrombin detection, and HIV therapy.
Why it matters
Drug delivery remains one of the biggest bottlenecks in medicine. CPPs provide a versatile, peptide-based solution that could make many existing and experimental therapies significantly more effective by solving the cellular entry problem.
The numbers in context
Covers cancer therapy, tumor imaging, atherosclerotic plaques, thrombin levels, and HIV therapy
How the study worked
Narrative review of published literature covering CPP mechanisms, therapeutic applications, tumor imaging uses, nanocarrier enhancement, stability challenges, and strategies to overcome them.
Who was studied
Review of published literature on CPP-nanotherapeutic applications
What this study cannot tell us
Review article with no new experimental data. CPP stability, off-target delivery, and potential immunogenicity remain unsolved challenges. Most applications discussed are still preclinical.
How to read the evidence
Not applicable (narrative review). Synthesizes existing literature without generating new experimental data.
When this study was published
Published in 2021. CPP research has continued to advance rapidly with newer targeting and stabilization strategies since publication.
The bigger picture
CPPs represent a growing toolkit in peptide-based drug delivery. As researchers solve stability and targeting challenges, CPPs could become standard components of nanomedicine platforms, making a wide range of therapies more effective by ensuring drugs actually reach inside cells.
Questions still open
- Can CPP stability be improved enough for routine clinical use in drug delivery?
- Which CPP sequences offer the best selectivity for diseased cells over healthy tissue?
- How do CPP-based delivery systems compare to other cell-entry strategies like lipid nanoparticles?
Common questions
What are cell-penetrating peptides?
Are CPP-based therapies available to patients yet?
Read the original research
Cell-penetrating peptides (CPPs): an overview of applications for improving the potential of nanotherapeutics.
Biomaterials science, 9(4), 1153-1188
Citation
Desale, Kalyani; Kuche, Kaushik; Jain, Sanyog. (2021). Cell-penetrating peptides (CPPs): an overview of applications for improving the potential of nanotherapeutics.. Biomaterials science, 9(4), 1153-1188. https://doi.org/10.1039/d0bm01755h